Skip to main content
Outrage over dapagliflozin withdrawal for type 1 diabetes in EU
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Outrage over dapagliflozin withdrawal for type 1 diabetes in EU
User login
Username
Password
Reset your password
Concept
Lead
score
Type 1 Diabetes Mellitus
1
1
SGLT2 Inhibitor
0
0.99
Type 2 Diabetes Mellitus
0
0.51
Europe
0
0.98
Food and Drug Administration (FDA)
0
0.33
NHS
0
0.3
Adverse Effects
0
0.25
Heart
0
0.25
Renal Disease
0
0.23
Board Certification
0
0.17
Ejection Fraction
0
0.17
Kidney
0
0.17
UK Site Content
0
0.17
Chronic Kidney Disease
0
0.16
Renal Failure
0
0.16
Cardiovascular Imaging
0
0.12
Patient Safety
0
0.09
Blood
0
0.08
Diabetic Ketoacidosis
0
0.08
Dorsum
0
0.08
Drug Withdrawal
0
0.08
Health Care Services
0
0.08
Heart Failure (HF)
0
0.08
Salary and Compensation
0
0.08
Addiction
0
0.03
Revenue and Practice Management
0
0.03
Urinary Tract Infection
0
0.03
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.7
Cardiology
0
0.9